Taken together, we propose that the activation of BRAF and MAPK1/3 affects the growth of the cancer cells by inducing cell death, while the decrease in the level of phosphorylated RAF1 and the activation of RPS6KA1 are both important in inhibiting cell migration, thereby antagonizing the spread of cancer. Here, RPS6KA1 is linked to cancer.